1	The	the	DT	_	6	det	_
2	UK	uk	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	based	base	VBN	_	6	amod	_
5	pharmaceuticals	pharmaceutical	NNS	_	6	nn	_
6	firm	firm	NN	p2=VBP	7	nsubj	7:A0=PAG
7	rejected	reject	VBD	pb=reject.01	0	root	_
8	the	the	DT	_	10	det	_
9	latest	late	JJS	_	10	amod	_
10	advance	advance	NN	_	7	dobj	7:A1=PPT
11	from	from	IN	_	10	prep	_
12	the	the	DT	_	14	det	_
13	Viagra	viagra	NNP	_	14	nn	_
14	maker	maker	NN	_	11	pobj	_
15	after	after	IN	_	17	mark	_
16	it	it	PRP	_	17	nsubj	17:A0=PAG
17	upped	up	VBD	pb=up.01	7	advcl	7:AM-TMP
18	the	the	DT	_	19	det	_
19	price	price	NN	_	17	dobj	17:A1=PPT;22:A1=PPT;24:A1=VSP
20	it	it	PRP	_	22	nsubjpass	24:A0=PAG
21	was	be	VBD	_	22	auxpass	_
22	prepared	prepare	VBN	p2=JJ|pb=prepare.02	19	rcmod	_
23	to	to	TO	_	24	aux	_
24	pay	pay	VB	pb=pay.01	22	xcomp	22:A2=PRP
25	over	over	IN	p2=RP	24	prep	24:AM-TMP
26	the	the	DT	_	27	det	_
27	weekend	weekend	NN	_	25	pobj	_
28	.	.	.	_	7	punct	_

1	AstraZeneca	astrazeneca	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	the	the	DT	_	4	det	_
4	deal	deal	NN	_	6	nsubj	6:A0=PAG
5	would	would	MD	_	6	aux	6:AM-MOD
6	bring	bring	VB	pb=bring.01	2	ccomp	2:A1=PPT
7	'	'	``	p2=''	6	punct	_
8	uncertainty	uncertainty	NN	_	6	dobj	6:A1=PPT
9	and	and	CC	_	8	cc	_
10	risk	risk	NN	p2=VB	8	conj	_
11	'	'	''	p2=,	10	punct	_
12	for	for	IN	_	8	prep	_
13	its	its	PRP$	_	14	poss	_
14	shareholders	shareholder	NNS	_	12	pobj	_
15	and	and	CC	_	8	cc	_
16	'	'	``	p2=''	17	punct	_
17	undervalues	undervalues	NNS	p2=IN	8	conj	_
18	the	the	DT	_	19	det	_
19	company	company	NN	_	8	conj	_
20	and	and	CC	_	19	cc	_
21	its	its	PRP$	_	23	poss	_
22	attractive	attractive	JJ	_	23	amod	_
23	prospects	prospect	NNS	_	19	conj	_
24	'	'	''	p2=POS	6	punct	_
25	.	.	.	_	2	punct	_

1	The	the	DT	_	4	det	_
2	US	us	NNP	_	4	nn	_
3	pharmaceutical	pharmaceutical	NN	p2=JJ	4	nn	_
4	giant	giant	NN	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	its	its	PRP$	_	8	poss	_
7	latest	late	JJS	_	8	amod	_
8	offer	offer	NN	p2=VBP	9	nsubj	_
9	worth	worth	JJ	p2=NN	5	ccomp	5:A1=PPT
10	£55	£0	IN	p2=,	9	prep	_
11	a	a	DT	_	12	det	_
12	share	share	NN	_	10	pobj	13:A0
13	represented	represented	VBD	p2=VBN|pb=represent.01	12	partmod	_
14	a	a	DT	_	18	det	_
15	15	0	CD	_	17	num	_
16	per	per	NN	_	17	nn	_
17	cent	cent	NN	_	18	nn	_
18	increase	increase	NN	p2=VB	13	dobj	13:A1
19	to	to	IN	_	18	prep	_
20	its	its	PRP$	_	22	poss	_
21	previous	previous	JJ	_	22	amod	_
22	proposal	proposal	NN	_	19	pobj	_
23	on	on	IN	_	22	prep	_
24	May	may	NNP	_	23	pobj	_
25	2	0	CD	_	24	num	_
26	and	and	CC	_	13	cc	_
27	would	would	MD	_	29	aux	29:AM-MOD
28	also	also	RB	_	29	advmod	29:AM-ADV
29	be	be	VB	pb=be.01	13	conj	_
30	its	its	PRP$	_	32	poss	_
31	final	final	JJ	_	32	amod	_
32	approach	approach	NN	_	29	attr	29:A2=PRD
33	.	.	.	_	5	punct	_

1	AstraZeneca	astrazeneca	NNP	_	4	poss	_
2	's	's	POS	_	1	possessive	_
3	share	share	NN	_	4	nn	_
4	price	price	NN	_	5	nsubj	5:A1;13:A1
5	tumbled	tumble	VBD	pb=tumble.01	0	root	_
6	13	0	CD	_	5	npadvmod	5:A2=EXT
7	per	per	IN	_	6	prep	_
8	cent 	cent 	NN	p2=NNS	7	pobj	_
9	or	or	CC	_	8	cc	_
10	600p	0p	NN	p2=NNS	8	conj	_
11	,	,	,	_	5	punct	_
12	to	to	TO	p2=IN	13	aux	_
13	£42	£0	VB	p2=CD|pb=£0.01	5	advcl	5:AM-PRP
14	per	per	IN	p2=FW	13	prep	_
15	share	share	NN	_	14	pobj	_
16	.	.	.	_	5	punct	_

1	The	the	DT	_	3	det	_
2	attempted	attempt	VBN	p2=VBD|pb=attempt.01	3	amod	_
3	takeover	takeover	NN	_	12	nsubj	12:A0=CAU;2:A1=PPT
4	of	of	IN	_	3	prep	_
5	the	the	DT	_	6	det	_
6	UK	uk	NNP	_	10	poss	_
7	's	's	POS	_	6	possessive	_
8	largest	large	JJS	_	10	amod	_
9	pharmaceutical	pharmaceutical	JJ	p2=NN	10	amod	_
10	firm	firm	NN	_	4	pobj	_
11	has	have	VBZ	_	12	aux	_
12	caused	cause	VBN	pb=cause.01	0	root	_
13	significant	significant	JJ	_	15	amod	_
14	political	political	JJ	_	15	amod	_
15	controversy	controversy	NN	_	12	dobj	12:A1=PPT
16	amid	amid	IN	_	12	prep	12:AM-LOC
17	warnings	warning	NNS	_	16	pobj	_
18	from	from	IN	_	17	prep	_
19	scientists	scientist	NNS	_	18	pobj	27:A0=PAG;29:A0=PPT
20	that	that	WDT	p2=IN	27	complm	_
21	research	research	NN	p2=VBP	27	nsubjpass	27:A1=PPT
22	and	and	CC	_	21	cc	_
23	development	development	NN	_	21	conj	_
24	could	could	MD	_	27	aux	27:AM-MOD
25	be	be	VB	_	27	auxpass	_
26	adversely	adversely	RB	_	27	advmod	27:AM-MNR
27	affected	affect	VBN	p2=JJ|pb=affect.01	19	rcmod	_
28	and	and	CC	_	27	cc	_
29	fears	fear	VBZ	p2=NNS|pb=fear.01	27	conj	_
30	over	over	IN	_	29	prep	29:AM-CAU
31	jobs	job	NNS	_	32	nn	_
32	losses	loss	NNS	_	30	pobj	_
33	.	.	.	_	12	punct	_

1	Politicians	politician	NNS	p2=NNPS	4	nsubj	4:A0=PAG
2	have	have	VBP	_	4	aux	_
3	also	also	RB	_	4	advmod	4:AM-DIS
4	accused	accuse	VBN	pb=accuse.01	0	root	_
5	Pfizer	pfizer	NNP	_	4	dobj	4:A1=PPT
6	of	of	IN	_	4	prep	4:A2=PRD
7	being	be	VBG	_	8	auxpass	_
8	driven	drive	VBN	pb=drive.02	6	pcomp	_
9	by	by	IN	_	8	agent	8:A0=PAG
10	other	other	JJ	_	11	amod	_
11	motivations	motivation	NNS	_	9	pobj	_
12	including	include	VBG	_	11	prep	_
13	a	a	DT	_	17	det	_
14	lower	low	JJR	_	17	amod	_
15	corporation	corporation	NN	_	17	nn	_
16	tax	tax	NN	_	17	nn	_
17	bill	bill	NN	_	12	pobj	_
18	.	.	.	_	4	punct	_

1	Corporation	corporation	NN	p2=NNP	2	nn	_
2	tax	tax	NN	_	6	nsubj	6:A1=PPT
3	in	in	IN	_	2	prep	_
4	the	the	DT	_	5	det	_
5	UK	uk	NNP	_	3	pobj	_
6	is	be	VBZ	pb=be.01	0	root	_
7	currently	currently	RB	_	6	advmod	6:AM-TMP
8	21	0	CD	_	10	num	_
9	per	per	NN	p2=IN	10	nn	_
10	cent	cent	NN	_	6	attr	6:A2=PRD
11	compared	compare	VBN	_	6	prep	6:AM-ADV
12	with	with	IN	_	11	prep	_
13	35	0	CD	_	15	num	_
14	per	per	NN	p2=IN	15	nn	_
15	cent	cent	NN	_	12	pobj	_
16	in	in	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	US	us	NNP	_	16	pobj	_
19	.	.	.	_	6	punct	_

1	Executives	executive	NNS	_	7	nsubj	7:A0=PAG
2	from	from	IN	_	1	prep	_
3	both	both	DT	p2=CC	4	det	_
4	AstraZeneca	astrazeneca	NNP	_	2	pobj	_
5	and	and	CC	_	4	cc	_
6	Pfizer	pfizer	NNP	_	4	conj	_
7	faced	face	VBD	pb=face.01	0	root	_
8	MPs	mp	NNS	p2=NNP	7	dobj	7:A1
9	on	on	IN	_	7	prep	_
10	two	#crd#	CD	_	13	num	_
11	separate	separate	JJ	_	13	amod	_
12	select	select	NN	p2=JJ	13	nn	_
13	committees	committee	NNS	_	9	pobj	_
14	last	last	JJ	_	15	amod	_
15	week	week	NN	_	7	npadvmod	7:AM-TMP
16	such	such	JJ	p2=PDT	18	nsubj	18:A1=PPT
17	has	have	VBZ	_	18	aux	_
18	been	be	VBN	pb=be.01	7	advcl	_
19	the	the	DT	_	20	det	_
20	concern	concern	NN	_	18	attr	18:A2=PRD
21	over	over	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	deal	deal	NN	_	21	pobj	_
24	.	.	.	_	7	punct	_

1	He	he	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	that	that	IN	_	16	complm	_
4	from	from	IN	_	16	prep	16:AM-TMP
5	the	the	DT	_	6	det	_
6	time	time	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	initial	initial	JJ	_	9	amod	_
9	talks	talk	NNS	_	7	pobj	_
10	in	in	IN	_	9	prep	_
11	January	january	NNP	_	10	pobj	_
12	,	,	,	_	16	punct	_
13	the	the	DT	_	15	det	_
14	US	us	NNP	_	15	nn	_
15	company	company	NN	_	16	nsubj	16:A0=PAG
16	had	have	VBD	pb=have.03	2	ccomp	2:A1=PPT
17	'	'	``	p2=''	16	punct	_
18	failed	fail	VBD	p2=VBN|pb=fail.01	16	ccomp	16:A1=PPT
19	to	to	TO	_	20	aux	_
20	make	make	VB	pb=make.02	18	xcomp	18:A2=PPT
21	a	a	DT	_	28	det	_
22	compelling	compelling	JJ	_	28	amod	_
23	strategic	strategic	JJ	_	28	amod	_
24	,	,	,	_	28	punct	_
25	business	business	NN	_	28	nn	_
26	or	or	CC	_	25	cc	_
27	value	value	NN	_	25	conj	_
28	case	case	NN	_	20	dobj	20:A1=PRD
29	'	'	''	_	16	punct	_
30	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	_	2	nsubj	2:A0;17:A0=PAG
2	said	say	VBD	pb=say.01	0	root	_
3	today	today	NN	_	2	npadvmod	2:AM-TMP
4	it	it	PRP	_	7	nsubj	7:A0=PAG
5	would	would	MD	_	7	aux	7:AM-MOD
6	not	not	RB	_	7	neg	7:AM-NEG
7	make	make	VB	pb=make.02	2	ccomp	2:A1=PPT
8	a	a	DT	_	10	det	_
9	hostile	hostile	JJ	_	10	amod	_
10	offer	offer	NN	_	11	nsubj	_
11	direct	direct	JJ	p2=VB	7	ccomp	7:A1=PRD
12	to	to	IN	p2=TO	11	prep	_
13	AstraZeneca	astrazeneca	NNP	_	14	nn	_
14	shareholders	shareholder	NNS	_	12	pobj	_
15	,	,	,	_	2	punct	_
16	instead	instead	RB	_	17	advmod	17:AM-ADV
17	urging	urge	VBG	pb=urge.01	2	advcl	2:AM-ADV
18	them	them	PRP	_	17	dobj	20:A0=PAG;26:A0=PAG;17:A1=PPT
19	to	to	TO	_	20	aux	_
20	press	press	VB	pb=press.01	17	xcomp	17:A2=PPT
21	the	the	DT	_	22	det	_
22	company	company	NN	_	24	poss	_
23	's	's	POS	_	22	possessive	_
24	board	board	NN	_	20	dobj	20:A1=PPT
25	to	to	TO	_	26	aux	_
26	begin	begin	VB	pb=begin.01	20	advcl	20:AM-PRP
27	substantive	substantive	JJ	_	28	amod	_
28	engagement	engagement	NN	_	26	dobj	26:A1=PPT
29	over	over	IN	_	28	prep	_
30	a	a	DT	_	31	det	_
31	deal	deal	NN	_	29	pobj	_
32	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	an	an	DT	_	4	det	_
4	offer	offer	NN	_	18	nsubjpass	5:A1;18:A1=PPT
5	made	make	VBN	p2=VBD|pb=make.LV	4	partmod	_
6	to	to	IN	p2=TO	5	prep	5:A2
7	Astra	astra	NNP	_	6	pobj	_
8	on	on	IN	_	5	prep	5:AM-TMP
9	Friday	friday	NNP	_	8	pobj	10:A0
10	valuing	value	VBG	pb=value.01	9	partmod	_
11	the	the	DT	_	12	det	_
12	firm	firm	NN	_	10	dobj	10:A1
13	at	at	IN	_	10	prep	10:A2=PRD
14	£53.50	£0	CD	p2=PDT	13	pobj	_
15	a	a	DT	_	16	det	_
16	share	share	NN	_	14	npadvmod	_
17	was	be	VBD	_	18	auxpass	_
18	rejected	reject	VBN	pb=reject.01	2	ccomp	2:A1=PPT
19	on	on	IN	_	18	prep	18:AM-LOC
20	the	the	DT	_	21	det	_
21	grounds	ground	NNS	_	19	pobj	24:A2=EXT
22	it	it	PRP	_	24	nsubj	24:A0=PAG
23	substantially	substantially	RB	_	24	advmod	24:AM-MNR
24	undervalued	undervalue	VBD	pb=undervalue.01	21	rcmod	_
25	the	the	DT	_	26	det	_
26	company	company	NN	_	24	dobj	24:A1=PPT
27	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nn	_
2	chief	chief	JJ	_	3	amod	_
3	executive	executive	NN	_	5	nn	_
4	Ian	ian	NNP	_	5	nn	_
5	Read	read	NNP	_	6	nsubj	6:A0
6	said	say	VBD	pb=say.01	0	root	_
7	:	:	:	_	6	punct	_
8	'	'	``	p2=''	6	punct	_
9	We	we	PRP	_	11	nsubj	11:A0=PAG;14:A0=PAG;22:A0=PAG
10	have	have	VBP	_	11	aux	_
11	tried	try	VBN	pb=try.01	6	ccomp	6:A1=PPT
12	repeatedly	repeatedly	RB	_	11	advmod	11:AM-MNR
13	to	to	TO	_	14	aux	_
14	engage	engage	VB	pb=engage.01	11	xcomp	11:A1=PPT
15	in	in	IN	_	14	prep	14:A2=PPT
16	a	a	DT	_	18	det	_
17	constructive	constructive	JJ	_	18	amod	_
18	process	process	NN	_	15	pobj	_
19	with	with	IN	_	18	prep	_
20	AstraZeneca	astrazeneca	NNP	_	19	pobj	_
21	to	to	TO	_	22	aux	_
22	explore	explore	VB	pb=explore.01	14	advcl	14:AM-PRP
23	a	a	DT	_	24	det	_
24	combination	combination	NN	_	22	dobj	22:A1
25	of	of	IN	_	24	prep	_
26	our	our	PRP$	_	28	poss	_
27	two	#crd#	CD	_	28	num	_
28	companies	company	NNS	_	25	pobj	_
29	.	.	.	_	6	punct	_

1	'	'	``	p2=''	13	punct	_
2	Following	follow	VBG	_	13	prep	13:AM-TMP
3	a	a	DT	_	4	det	_
4	conversation	conversation	NN	_	2	pobj	_
5	with	with	IN	_	4	prep	_
6	AstraZeneca	astrazeneca	NNP	_	5	pobj	_
7	earlier	early	RBR	_	8	advmod	_
8	today	today	NN	_	4	npadvmod	_
9	,	,	,	_	13	punct	_
10	we	we	PRP	_	13	nsubj	13:A0=PAG
11	do	do	VBP	_	13	aux	_
12	not	not	RB	_	13	neg	13:AM-NEG
13	believe	believe	VB	pb=believe.01	0	root	_
14	that	that	IN	_	18	complm	_
15	the	the	DT	_	17	det	_
16	AstraZeneca	astrazeneca	NNP	_	17	nn	_
17	board	board	NN	_	18	nsubj	22:A0=PAG;18:A1=PPT
18	is	be	VBZ	pb=be.01	13	ccomp	13:A1=PPT
19	currently	currently	RB	_	18	advmod	18:AM-TMP
20	prepared	prepared	JJ	p2=VBN	18	acomp	18:A2=PRD
21	to	to	TO	_	22	aux	_
22	recommend	recommend	VB	pb=recommend.01	20	xcomp	_
23	a	a	DT	_	24	det	_
24	deal	deal	NN	_	22	dobj	22:A1=PPT
25	at	at	IN	_	22	prep	22:A3=PRD
26	a	a	DT	_	28	det	_
27	reasonable	reasonable	JJ	_	28	amod	_
28	price	price	NN	_	25	pobj	_
29	.	.	.	_	13	punct	_

1	'	'	``	p2=''	3	punct	_
2	We	we	PRP	_	3	nsubj	6:A0=PAG;3:A1=PPT
3	remain	remain	VBP	pb=remain.01	0	root	_
4	ready	ready	JJ	_	3	acomp	3:A3=PRD
5	to	to	TO	_	6	aux	_
6	engage	engage	VB	pb=engage.01	4	xcomp	_
7	in	in	IN	_	6	prep	6:A2=PPT
8	a	a	DT	_	10	det	_
9	meaningful	meaningful	JJ	_	10	amod	_
10	dialogue	dialogue	NN	_	7	pobj	_
11	but	but	CC	p2=IN	3	cc	_
12	time	time	NN	_	17	nsubj	17:A1=LOC
13	for	for	IN	_	12	prep	_
14	constructive	constructive	JJ	_	15	amod	_
15	engagement	engagement	NN	_	13	pobj	_
16	is	be	VBZ	_	17	aux	_
17	running	run	VBG	pb=run.02	3	conj	_
18	out	out	RP	_	17	prt	17:C-V
19	.	.	.	_	17	punct	_

1	Without	without	IN	_	20	prep	20:AM-MNR
2	further	far	JJ	_	3	amod	_
3	discussions	discussion	NNS	_	1	pobj	_
4	or	or	CC	_	3	cc	_
5	an	an	DT	_	6	det	_
6	extension	extension	NN	_	3	conj	_
7	of	of	IN	_	6	prep	_
8	the	the	DT	_	9	det	_
9	deadline	deadline	NN	_	7	pobj	_
10	for	for	IN	_	9	prep	_
11	making	make	VBG	pb=make.LV	10	pcomp	_
12	a	a	DT	_	14	det	_
13	firm	firm	JJ	p2=NN	14	amod	_
14	offer	offer	NN	_	11	dobj	11:AM-PRR
15	,	,	,	_	20	punct	_
16	Pfizer	pfizer	NNP	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	proposal	proposal	NN	_	20	nsubj	20:A1=PPT
19	will	will	MD	_	20	aux	20:AM-MOD
20	expire	expire	VB	pb=expire.01	0	root	_
21	at	at	IN	_	20	prep	20:AM-TMP
22	5	0	CD	_	23	num	_
23	pm	pm	NN	_	21	pobj	_
24	on	on	IN	_	20	prep	20:AM-TMP
25	May	may	NNP	_	24	pobj	_
26	26	0	CD	_	25	num	_
27	.	.	.	_	20	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	5	nsubj	5:A0=PAG;21:A0
3	has	have	VBZ	_	5	aux	_
4	also	also	RB	_	5	advmod	5:AM-DIS
5	increased	increase	VBN	pb=increase.01	0	root	_
6	the	the	DT	_	8	det	_
7	cash	cash	NN	_	8	nn	_
8	element	element	NN	_	5	dobj	5:A1=PPT
9	of	of	IN	_	8	prep	_
10	its	its	PRP$	_	11	poss	_
11	offer	offer	NN	_	9	pobj	_
12	from	from	IN	_	5	prep	5:A3=DIR
13	33	0	CD	_	12	pobj	_
14	per	per	IN	p2=NN	13	prep	_
15	cent	cent	NN	_	14	pobj	_
16	to	to	IN	_	5	prep	5:A4=GOL
17	45	0	CD	_	19	num	_
18	per	per	NN	p2=IN	19	nn	_
19	cent	cent	NN	_	16	pobj	_
20	and	and	CC	_	5	cc	_
21	said	say	VBD	pb=say.01	5	conj	_
22	its	its	PRP$	_	24	poss	_
23	latest	late	JJS	_	24	amod	_
24	proposal	proposal	NN	_	25	nsubj	25:A1=PPT
25	was	be	VBD	pb=be.01	21	ccomp	21:A1=PPT
26	34	0	CD	_	28	num	_
27	per	per	NN	p2=IN	28	nn	_
28	cent	cent	NN	_	29	npadvmod	_
29	higher	high	JJR	p2=RBR	25	acomp	25:A2=PRD
30	than	than	IN	_	29	prep	_
31	Astra	astra	NNP	_	39	poss	_
32	's	's	POS	p2=VBZ	31	possessive	_
33	all	all	DT	p2=JJ	35	hmod	_
34	-	-	HYPH	_	35	hyph	_
35	time	time	NN	_	39	nn	_
36	high	high	JJ	p2=NN	37	amod	_
37	closing	closing	NN	p2=VBG	39	nn	_
38	share	share	NN	_	39	nn	_
39	price	price	NN	_	30	pobj	_
40	prior	prior	RB	_	39	advmod	_
41	to	to	IN	_	40	prep	_
42	the	the	DT	_	44	det	_
43	bid	bid	NN	p2=JJ	44	nn	_
44	speculation	speculation	NN	_	41	pobj	_
45	.	.	.	_	5	punct	_

1	Pfizer	pfizer	NNP	p2=NN	4	nsubj	4:A0=PAG
2	has	have	VBZ	_	4	aux	_
3	already	already	RB	_	4	advmod	4:AM-TMP
4	pledged	pledge	VBN	pb=pledge.01	0	root	_
5	in	in	IN	_	4	prep	4:AM-LOC
6	a	a	DT	_	7	det	_
7	letter	letter	NN	_	5	pobj	_
8	to	to	IN	_	7	prep	_
9	Prime	prime	NNP	_	10	nn	_
10	Minister	minister	NNP	_	12	nn	_
11	David	david	NNP	_	12	nn	_
12	Cameron	cameron	NNP	_	8	pobj	_
13	that	that	IN	_	18	complm	_
14	any	any	DT	_	15	det	_
15	deal	deal	NN	_	18	nsubj	18:A0=PAG
16	would	would	MD	_	18	aux	18:AM-MOD
17	not	not	RB	_	18	neg	18:AM-NEG
18	stop	stop	VB	pb=stop.01	4	ccomp	4:A2=PPT
19	the	the	DT	_	20	det	_
20	building	building	NN	_	18	dobj	18:A1=PPT
21	of	of	IN	_	20	prep	_
22	Astra	astra	NNP	_	28	poss	_
23	's	's	POS	_	22	possessive	_
24	planned	plan	VBN	p2=JJ|pb=plan.01	28	amod	_
25	research	research	NN	_	28	nn	_
26	and	and	CC	_	25	cc	_
27	development	development	NN	_	25	conj	_
28	hub	hub	NN	_	21	pobj	24:A1=PPT
29	in	in	IN	_	28	prep	_
30	Cambridge	cambridge	NNP	_	29	pobj	_
31	and	and	CC	_	18	cc	_
32	that	that	IN	p2=DT	44	mark	_
33	20	0	CD	_	35	num	_
34	per	per	NN	p2=IN	35	nn	_
35	cent	cent	NN	_	44	nsubj	44:A1=PPT
36	of	of	IN	_	35	prep	_
37	the	the	DT	_	39	det	_
38	combined	combine	VBN	p2=JJ|pb=combine.01	39	amod	_
39	company	company	NN	_	42	poss	38:A1=PPT
40	's	's	POS	_	39	possessive	_
41	R&D	r&d	NN	_	42	nn	_
42	workforce	workforce	NN	_	36	pobj	_
43	will	will	MD	_	44	aux	44:AM-MOD
44	be	be	VB	pb=be.01	18	conj	_
45	in	in	IN	_	44	prep	44:A2=PRD
46	the	the	DT	_	47	det	_
47	UK	uk	NNP	_	45	pobj	_
48	.	.	.	_	4	punct	_

1	But	but	CC	_	3	cc	3:AM-DIS
2	Astra	astra	NNP	_	3	nsubj	3:A0=PAG
3	believes	believe	VBZ	pb=believe.01	0	root	_
4	Pfizer	pfizer	NNP	_	6	poss	_
5	's	's	POS	_	4	possessive	_
6	board	board	NN	_	8	nsubj	8:A0=PAG
7	is	be	VBZ	_	8	aux	_
8	making	make	VBG	pb=make.02	3	ccomp	3:A1=PPT
9	an	an	DT	_	11	det	_
10	opportunistic	opportunistic	JJ	_	11	amod	_
11	attempt	attempt	NN	_	8	dobj	8:AM-PRR
12	to	to	TO	_	13	aux	_
13	acquire	acquire	VB	pb=acquire.01	11	infmod	_
14	'	'	''	_	13	punct	_
15	a	a	DT	_	17	det	_
16	transformed	transform	VBN	p2=JJ|pb=transform.01	17	amod	_
17	AstraZeneca	astrazeneca	NNP	_	13	dobj	13:A1=PPT;16:A1=PPT
18	,	,	,	_	17	punct	_
19	without	without	IN	_	16	prep	16:AM-MNR
20	reflecting	reflect	VBG	pb=reflect.01	19	pcomp	_
21	the	the	DT	_	22	det	_
22	value	value	NN	_	20	dobj	20:A1=PPT
23	of	of	IN	_	22	prep	_
24	its	its	PRP$	_	26	poss	_
25	exciting	exciting	JJ	_	26	amod	_
26	pipeline	pipeline	NN	_	23	pobj	_
27	'	'	''	p2=POS	26	punct	_
28	.	.	.	_	3	punct	_

1	Chief	chief	NNP	p2=JJ	2	nn	_
2	executive	executive	NN	p2=JJ	4	nn	_
3	Pascal	pascal	NNP	_	4	nn	_
4	Soriot	soriot	NNP	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	the	the	DT	_	9	det	_
7	mega	mega	JJ	p2=NN	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	merger	merger	NN	_	11	nsubj	11:A0
10	would	would	MD	_	11	aux	11:AM-MOD
11	prove	prove	VB	pb=prove.01	5	ccomp	5:A1=PPT
12	a	a	DT	_	13	det	_
13	distraction	distraction	NN	_	11	dobj	11:A1=PPT
14	from	from	IN	_	13	prep	_
15	its	its	PRP$	_	17	poss	_
16	scientific	scientific	JJ	_	17	amod	_
17	priorities	priority	NNS	_	14	pobj	_
18	.	.	.	_	5	punct	_

1	And	and	CC	_	8	cc	8:AM-DIS
2	Pfizer	pfizer	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	pledges	pledge	NNS	_	8	nsubjpass	8:A1
5	have	have	VBP	_	8	aux	_
6	also	also	RB	_	8	advmod	8:AM-DIS
7	been	be	VBN	_	8	auxpass	_
8	criticised	criticise	VBN	pb=criticise.01	0	root	_
9	by	by	IN	_	8	agent	8:A0
10	the	the	DT	_	11	det	_
11	President	president	NNP	_	9	pobj	18:A0
12	of	of	IN	_	11	prep	_
13	the	the	DT	_	15	det	_
14	Royal	royal	NNP	_	15	nn	_
15	Society	society	NNP	_	12	pobj	_
16	,	,	,	_	11	punct	_
17	who	who	WP	_	18	nsubj	18:R-A0
18	said	say	VBD	pb=say.01	11	rcmod	_
19	they	they	PRP	_	20	nsubj	20:A1=PPT
20	were	be	VBD	pb=be.01	18	ccomp	18:A1=PPT
21	'	'	``	p2=VBN	20	punct	_
22	vague	vague	JJ	p2=UH	20	acomp	20:A2=PRD
23	,	,	,	_	24	punct	_
24	come	come	VB	p2=VBP|pb=come.01	20	xcomp	_
25	with	with	IN	_	24	prep	24:A1=PPT
26	caveats	caveat	NNS	_	25	pobj	_
27	and	and	CC	_	24	cc	_
28	have	have	VBP	p2=VB|pb=have.03	24	conj	_
29	an	an	DT	_	31	det	_
30	inappropriate	inappropriate	JJ	_	31	amod	_
31	timescale	timescale	NN	_	28	dobj	28:A1=PPT
32	'	'	''	_	31	punct	_
33	.	.	.	_	8	punct	_

1	Meanwhile	meanwhile	RB	_	5	advmod	5:AM-TMP
2	Swedish	swedish	JJ	_	4	amod	_
3	trade	trade	NN	_	4	nn	_
4	unions	union	NNS	_	5	nsubj	5:A0=PAG
5	warned	warn	VBD	p2=VBN|pb=warn.01	0	root	_
6	over	over	IN	_	5	prep	5:AM-TMP
7	the	the	DT	_	8	det	_
8	weekend	weekend	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	negative	negative	JJ	_	12	amod	_
12	consequences	consequence	NNS	_	9	pobj	15:A1=PPT
13	that	that	WDT	_	15	nsubj	15:R-A1
14	would	would	MD	_	15	aux	15:AM-MOD
15	arise	arise	VB	pb=arise.01	12	rcmod	_
16	from	from	IN	_	15	prep	15:A2=LOC
17	the	the	DT	_	19	det	_
18	proposed	propose	VBN	p2=JJ|pb=propose.01	19	amod	_
19	takeover	takeover	NN	_	16	pobj	18:A1=PPT
20	.	.	.	_	5	punct	_

1	In	in	IN	_	22	prep	22:AM-TMP
2	2003	0	CD	_	1	pobj	_
3	when	when	WRB	_	5	advmod	5:R-AM-TMP
4	Pfizer	pfizer	NNP	_	5	nsubj	5:A0=PAG
5	bought	buy	VBD	pb=buy.01	22	advcl	_
6	rival	rival	JJ	p2=NN	7	amod	_
7	Pharmacia	pharmacia	NNP	_	5	dobj	5:A1=PPT;11:A1=PPT
8	,	,	,	_	7	punct	_
9	which	which	WDT	_	11	nsubjpass	11:R-A1
10	was	be	VBD	_	11	auxpass	_
11	founded	found	VBN	pb=found.01	7	rcmod	_
12	in	in	IN	_	11	prep	11:AM-TMP
13	1911	0	CD	_	12	pobj	_
14	in	in	IN	_	11	prep	11:AM-LOC
15	Stockholm	stockholm	NNP	_	14	pobj	_
16	,	,	,	_	22	punct	_
17	the	the	DT	_	19	det	_
18	Swedish	swedish	JJ	_	19	amod	_
19	operations	operation	NNS	_	22	nsubjpass	22:A1=PPT
20	were	be	VBD	_	22	auxpass	_
21	significantly	significantly	RB	_	22	advmod	22:AM-MNR
22	scaled	scale	VBN	pb=scale.01	0	root	_
23	down	down	RP	_	22	prt	22:A5=VSP
24	,	,	,	_	22	punct	_
25	and	and	CC	_	22	cc	_
26	only	only	RB	_	28	advmod	_
27	a	a	DT	_	28	det	_
28	fraction	fraction	NN	_	30	nsubj	30:A1=PPT
29	now	now	RB	_	30	advmod	30:AM-TMP
30	remain	remain	VBP	p2=VB|pb=remain.01	22	conj	_
31	.	.	.	_	30	punct	_

1	Sweden	sweden	NNP	_	4	poss	_
2	's	's	POS	_	1	possessive	_
3	finance	finance	NN	_	4	nn	_
4	minister	minister	NN	_	8	nsubj	8:A0=PAG
5	has	have	VBZ	_	8	aux	_
6	also	also	RB	_	8	advmod	8:AM-DIS
7	previously	previously	RB	_	8	advmod	8:AM-TMP
8	warned	warn	VBN	p2=VBD|pb=warn.01	0	root	_
9	that	that	IN	p2=WDT	16	complm	_
10	promises	promise	NNS	_	16	nsubjpass	16:A1=PPT;11:AM-PRR
11	made	make	VBN	pb=make.01	10	partmod	_
12	by	by	IN	_	11	agent	11:A0=PAG
13	Pfizer	pfizer	NNP	_	12	pobj	_
14	should	should	MD	_	16	aux	16:AM-MOD
15	be	be	VB	_	16	auxpass	_
16	taken	take	VBN	pb=take.01	8	ccomp	8:A1=PPT
17	with	with	IN	_	16	prep	16:AM-MNR
18	a	a	DT	_	20	det	_
19	'	'	``	p2=''	20	punct	_
20	sack	sack	NN	_	17	pobj	_
21	full	full	JJ	_	20	amod	_
22	of	of	IN	_	21	prep	_
23	salt	salt	NN	_	22	pobj	_
24	'	'	''	p2=VBN	20	punct	_
25	by	by	IN	_	20	prep	_
26	Astra	astra	NNP	p2=JJ	27	nn	_
27	executives	executive	NNS	_	25	pobj	_
28	and	and	CC	_	27	cc	_
29	the	the	DT	_	31	det	_
30	UK	uk	NNP	_	31	nn	_
31	government	government	NN	_	27	conj	_
32	.	.	.	_	8	punct	_

1	The	the	DT	_	2	det	_
2	comments	comment	NNS	_	7	nsubjpass	7:A1=PPT
3	below	below	RB	p2=WDT	2	advmod	_
4	have	have	VBP	_	7	aux	_
5	not	not	RB	_	7	neg	7:AM-NEG
6	been	be	VBN	_	7	auxpass	_
7	moderated	moderate	VBN	pb=moderate.01	0	root	_
8	.	.	.	_	7	punct	_

1	The	the	DT	_	2	det	_
2	views	view	NNS	_	8	nsubj	3:A1=PPT;8:A1=PPT;17:A2=PAG
3	expressed	express	VBD	p2=VBN|pb=express.01	2	partmod	_
4	in	in	IN	_	3	prep	3:AM-MNR
5	the	the	DT	_	6	det	_
6	contents	content	NNS	_	4	pobj	_
7	above	above	RB	p2=IN	6	advmod	_
8	are	be	VBP	pb=be.01	0	root	_
9	those	those	DT	_	8	attr	8:A2=PRD
10	of	of	IN	_	9	prep	_
11	our	our	PRP$	_	12	poss	_
12	users	user	NNS	_	10	pobj	_
13	and	and	CC	_	8	cc	_
14	do	do	VBP	_	17	aux	_
15	not	not	RB	_	17	neg	17:AM-NEG
16	necessarily	necessarily	RB	_	17	advmod	17:AM-ADV
17	reflect	reflect	VB	pb=reflect.01	8	conj	_
18	the	the	DT	_	19	det	_
19	views	view	NNS	_	17	dobj	17:A1=PPT
20	of	of	IN	_	19	prep	_
21	MailOnline	mailonline	NNP	_	20	pobj	_
22	.	.	.	_	17	punct	_

1	By	by	IN	_	6	prep	6:AM-MNR
2	posting	post	VBG	pb=post.01	1	pcomp	_
3	your	your	PRP$	_	4	poss	_
4	comment	comment	NN	_	2	dobj	2:A1=PPT
5	you	you	PRP	_	6	nsubj	6:A0=PAG
6	agree	agree	VBP	pb=agree.01	0	root	_
7	to	to	IN	_	6	prep	6:A1=PPT
8	our	our	PRP$	_	10	poss	_
9	house	house	NN	_	10	nn	_
10	rules	rule	NNS	_	7	pobj	_
11	.	.	.	_	6	punct	_

